FDA issued a Warning Letter to Human Biologics of Texas/Globus Medical on 10/30/2018 as a result of this inspection.
FDA investigators audited the Human Biologics of Texas - San Antonio, TX, United States facility and issued inspectional observations (via FDA 483) on 19 Apr 2018.
Product details
- Category: Biologics
- Inspection end: 19 Apr 2018
- Location: San Antonio, United States
- FEI: 3006226621
